Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBMYBristol Myers Squibb
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | BMY | GILD |
|---|
| Close | 62.48 | 170.68 |
| Market Cap | $128B | $213B |
| 1M | +0.13% | +14.51% |
| P/E (TTM) | 13.8 | — |
| Forward P/E | 9.3 | 22.0 |
| P/E 5-Yr Percentile | 27 | — |
| P/S | 2.6 | 7.0 |
| P/B | 5.7 | 17.9 |
| Dividend Yield | 4.58% | 3.98% |
| Latest Quarter Revenue | $13.1B | $8.3B |
| Revenue YoY | +6.9% | +6.8% |
| Gross Margin | 68.3% | 81.1% |
| Latest Quarter EPS | 1.05 | 1.94 |
| Avg Post-Earnings Move | ±2.2% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.98% | 2.57% |
| 90-Day Net Insider Buying | −$0.44M | −$15.9M |
BMY · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
